Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Spectrum Pharmaceuticals Announces That FDA Has Accepted FUSILEV sNDA for Colorectal Cancer Indication
Spectrum Pharmaceuticals Announces That FDA Has Accepted FUSILEV sNDA for Colorectal Cancer Indication
Spectrum Pharmaceuticals Announces That FDA Has Accepted FUSILEV sNDA for Colorectal Cancer Indication
Submitted by
admin
on March 26, 2009 - 7:50am
Source:
Yahoo
News Tags:
Spectrum Pharmaceuticals
Fusilev
colon cancer
sNDA
FDA
Headline:
Spectrum Pharmaceuticals Announces That FDA Has Accepted FUSILEV sNDA for Colorectal Cancer Indication
Do Not Allow Advertisers to Use My Personal information
